Dose Escalation of Second-Line Sunitinib Results in Rapid Partial Remission of Multiple Hepatic Metastases

Canadian Urological Association Journal - Canada
doi 10.5489/cuaj.1190
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Canadian Urological Association Journal

Related search

Tanespimycin Monotherapy in Relapsed Multiple Myeloma: Results of a Phase 1 Dose-Escalation Study

British Journal of Haematology
Hematology
2010English

Clozapine – Induced Neuroleptic Malignant Syndrome Associated With Rapid Dose Escalation

Dusunen Adam
PsychiatryMental HealthNeurology
2015English

Survival Benefits of Second-Line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2020English

Early Results of Surgical Treatment of Hepatic Metastases of Colorectal Carcinoma

Scripta Medica
2009English

Durable Remission With Salvage Second Autotransplants in Patients With Multiple Myeloma

Cancer
Cancer ResearchOncology
2011English

Partial Clinical Remission in Type 1 Diabetes: A Comparison of the Accuracy of Total Daily Dose of Insulin of <0.3 Units/Kg/Day to the Gold Standard Insulin-Dose Adjusted Hemoglobin A1c of ≤9 for the Detection of Partial Clinical Remission

Journal of Pediatric Endocrinology and Metabolism
Child HealthEndocrinologyPerinatologyPediatricsMetabolismDiabetes
2017English

Pleomorphic Carcinoma Showing Rapid Growth, Multiple Metastases, and Intestinal Perforation

Annals of Thoracic and Cardiovascular Surgery
GastroenterologyCardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2014English

Cost-Effectiveness of Rapid Susceptibility Testing Against Second-Line Drugs for Tuberculosis

International Journal of Tuberculosis and Lung Disease
MedicinePulmonaryInfectious DiseasesRespiratory Medicine
2014English

Pcn115 a Cross-Country Comparison of Second-Line Multiple Myeloma Treatments

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy